antineoplastic combined chemotherapy protocols / adverse effects

Explore academic connections and research related to this keyword

269
Views
6
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Chiappella A;Martelli M;Angelucci E;Brusamolino E;Evangelista A;Carella AM;Stelitano C;Rossi G;Balza...
2017 the lancet oncology 507 views
2
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial
Vitolo U;Chiappella A;Ferreri AJ;Martelli M;Baldi I;Balzarotti M;Bottelli C;Conconi A;Gomez H;Lopez-...
2011 journal of clinical oncology : official journal of... 511 views
3
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
Rowe JM;Andersen JW;Mazza JJ;Bennett JM;Paietta E;Hayes FA;Oette D;Cassileth PA;Stadtmauer EA;Wierni...
1995 Blood 418 views
4
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Palumbo A;Hajek R;Delforge M;Kropff M;Petrucci MT;Catalano J;Gisslinger H;Wiktor-Jędrzejczak W;Zodel...
2012 The New England journal of medicine 437 views
5
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Dimopoulos MA;Terpos E;Boccadoro M;Delimpasi S;Beksac M;Katodritou E;Moreau P;Baldini L;Symeonidis A...
2021 The Lancet. Oncology 443 views
6
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
Gay F;Oliva S;Petrucci MT;Conticello C;Catalano L;Corradini P;Siniscalchi A;Magarotto V;Pour L;Carel...
2015 The Lancet. Oncology 338 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

transplantation National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male middle aged Comparative Study risk factors Clinical Trial Phase III